Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inogen Inc (INGN)
:INGN
INGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.82 - $13.33
Previous CloseN/A
Volume110.44K
Average Volume (3M)279.09K
Market Cap
$244.85M
Enterprise Value$126.28M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.03
Next Earnings
Feb 25, 2025EPS Estimate
-0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.25
Shares Outstanding23,818,413
10 Day Avg. Volume287,771
30 Day Avg. Volume279,086
Standard Deviation0.17
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.74
Price to Cash Flow (P/CF)8.80
P/FCF Ratio11.50
Enterprise Value/Market Cap0.52
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.00
Enterprise Value/Ebitda-3.06
Forecast
1Y Price Target
$10.00Price Target Upside-2.72% Downside
Rating ConsensusHold
Number of Analyst Covering2
---
Inogen News
PremiumCompany Announcements
Inogen Board Reshuffle with Sahney Appointment
PremiumCompany Announcements
Inogen Announces Strategic Collaboration with Yuwell
PremiumCompany Announcements
Inogen Expands U.S. Market with FDA Clearance---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceINGN preannounced 4Q24 revenue of $79.0-80.0M, above consensus of $74.0M.
Market OpportunityPhilips' exit from the respiratory equipment market in the US has created an opportunity in the SOC category for INGN.
Strategic CollaborationINGN announced a new strategic collaboration with the Chinese medical device manufacturer Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Bears Say
Direct-to-consumer SalesThe company continues to work to stabilize its DTC business.
Sales PerformanceDTC sales fell short of expectations due to a decline in sales rep headcount.
Sustained ProfitabilityThere is still a long way to go for INGN to reach sustained profitability.
---
Ownership Overview
1.53% Insiders
21.27% Mutual Funds
30.23% Other Institutional Investors
35.91% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INGN FAQ
What was Inogen Inc’s price range in the past 12 months?
Inogen Inc lowest stock price was $5.82 and its highest was $13.33 in the past 12 months.
What is Inogen Inc’s market cap?
Inogen Inc’s market cap is $244.85M.
When is Inogen Inc’s upcoming earnings report date?
Inogen Inc’s upcoming earnings report date is Feb 25, 2025 which is in 3 days.
How were Inogen Inc’s earnings last quarter?
Inogen Inc released its earnings results on Nov 07, 2024. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.496 by $0.246.
Is Inogen Inc overvalued?
According to Wall Street analysts Inogen Inc’s price is currently Overvalued.
Does Inogen Inc pay dividends?
Inogen Inc does not currently pay dividends.
What is Inogen Inc’s EPS estimate?
Inogen Inc’s EPS estimate is -0.61.
How many shares outstanding does Inogen Inc have?
Inogen Inc has 23,818,413 shares outstanding.
What happened to Inogen Inc’s price movement after its last earnings report?
Inogen Inc reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.496. Following the earnings report the stock price went up 17.23%.
Which hedge fund is a major shareholder of Inogen Inc?
Currently, no hedge funds are holding shares in INGN
---
Inogen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$10.00 (-2.72% Downside)
$10.00 (-2.72% Downside)
Blogger Sentiment
Bullish
INGN Sentiment 70%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 10.8%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.32%
12-Months-Change
Fundamentals
Return on Equity
-25.33%
Trailing 12-Months
Asset Growth
-10.92%
Trailing 12-Months
Company Description
Inogen Inc
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
---
INGN Company Deck
---
INGN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view with significant revenue growth, especially in business-to-business channels, and positive cash flow as key highlights. However, challenges remain in the direct-to-consumer and rental segments, with increasing operating expenses and anticipated adjusted EBITDA losses being notable lowlights.Read More>---
INGN Stock 12 Month Forecast
Average Price Target
$10.00
▼(-2.72% Downside)
Technical Analysis
Boston Scientific
―
Orthofix
―
Zimmer Biomet Holdings
―
Nevro Corp
―
TransMedics Group
―
Best Analysts Covering INGN
1 Year
1 Year Success Rate
12/18 ratings generated profit
1 Year Average Return
+23.06%
reiterated a sell rating 4 months ago
Copying Robbie Marcus's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +23.06% per trade.
---